Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000188
Filing Date
2025-03-24
Accepted
2025-03-24 06:10:17
Documents
114
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3757401
2 ex2-11.htm EX-2.11 29197
3 ex19-1.htm EX-19.1 65607
4 ex19-2.htm EX-19.2 5868
5 ex21-1.htm EX-21.1 1748
6 ex23-1.htm EX-23.1 2675
7 ex31-1.htm EX-31.1 11431
8 ex31-2.htm EX-31.2 11326
9 ex32-1.htm EX-32.1 11676
10 form10-k_001.jpg GRAPHIC 21259
11 form10-k_002.jpg GRAPHIC 121282
12 form10-k_004.jpg GRAPHIC 185310
13 form10-k_005.jpg GRAPHIC 35281
14 form10-k_006.jpg GRAPHIC 2372
15 form10-k_007.jpg GRAPHIC 2496
16 form10-k_008.jpg GRAPHIC 2384
17 form10-k_009.jpg GRAPHIC 2385
18 form10-k_0010.jpg GRAPHIC 2380
19 form10-k_0012.jpg GRAPHIC 3023
20 form10-k_0013.jpg GRAPHIC 2948
21 form10-k_0014.jpg GRAPHIC 16783
22 form10-k_0015.jpg GRAPHIC 16460
23 form10-k_0016.jpg GRAPHIC 15074
24 form10-k_0017.jpg GRAPHIC 19472
25 form10-k_0018.jpg GRAPHIC 19070
26 form10-k_021.jpg GRAPHIC 68660
27 form10-k_022.jpg GRAPHIC 39235
28 form10-k_023.jpg GRAPHIC 124917
  Complete submission text file 0001641172-25-000188.txt   15378202

Data Files

Seq Description Document Type Size
29 XBRL SCHEMA FILE evfm-20241231.xsd EX-101.SCH 76827
30 XBRL CALCULATION FILE evfm-20241231_cal.xml EX-101.CAL 87903
31 XBRL DEFINITION FILE evfm-20241231_def.xml EX-101.DEF 345579
32 XBRL LABEL FILE evfm-20241231_lab.xml EX-101.LAB 675849
33 XBRL PRESENTATION FILE evfm-20241231_pre.xml EX-101.PRE 530613
117 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2174569
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36754 | Film No.: 25762145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)